United Biotech Private Limited — Amphotericin Exporter Profile
Indian Pharmaceutical Exporter · #11 for Amphotericin · $319.8K export value · DGFT Verified
United Biotech Private Limited is the #11 Indian exporter of Amphotericin with $319.8K in export value and 27 verified shipments. United Biotech Private Limited holds a 0.4% market share in Amphotericin exports across 13 countries. The company exports 30 pharmaceutical products worth $7.0M across 7 therapeutic categories.
United Biotech Private Limited — Amphotericin Export Profile: Buyers & Destinations

Where Does United Biotech Private Limited Export Amphotericin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PARAGUAY | $184.5K | 4 | 63.7% |
| ECUADOR | $35.4K | 4 | 12.2% |
| HONDURAS | $23.5K | 1 | 8.1% |
| GAUTEMALA | $17.5K | 2 | 6.0% |
| TUNISIA | $16.4K | 2 | 5.6% |
| THAILAND | $4.4K | 1 | 1.5% |
| ANGOLA | $3.5K | 1 | 1.2% |
| COTE D IVOIRE | $2.1K | 1 | 0.7% |
| NEPAL | $1.6K | 7 | 0.6% |
| GHANA | $595 | 1 | 0.2% |
United Biotech Private Limited exports Amphotericin to 13 countries. The largest destination is PARAGUAY accounting for 63.7% of United Biotech Private Limited's Amphotericin shipments, followed by ECUADOR (12.2%) and HONDURAS (8.1%). These destinations reflect United Biotech Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Amphotericin from United Biotech Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| PROSALUD FARMA S.A. | PARAGUAY | $184.5K | 4 |
| TO THE ORDER | HONDURAS | $23.5K | 1 |
| ZETI PHARMACEUTICAL CIA LTDA | ECUADOR | $22.0K | 2 |
| SUNBRIGHT ASSOCIATES L.L.C-FZ. | GAUTEMALA | $17.5K | 1 |
| ZETI PHARMACEUTICAL CIA. LTDA. | ECUADOR | $11.8K | 1 |
| PHARMACIE CENTRALE DE TUNISIE | TUNISIA | $11.2K | 1 |
| PHARMACIE CENTRALE DE | TUNISIA | $5.1K | 1 |
| CBF PHARMA CO. LTD | THAILAND | $4.4K | 1 |
| PLURIBUS INTERNATIONAL | ANGOLA | $3.5K | 1 |
| NOUVELLE, PSP CI, | COTE D IVOIRE | $2.1K | 1 |
United Biotech Private Limited supplies Amphotericin to 21 buyers globally. The largest buyer is PROSALUD FARMA S.A. (PARAGUAY), followed by TO THE ORDER (HONDURAS) and ZETI PHARMACEUTICAL CIA LTDA (ECUADOR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Amphotericin Export Value and How Much Does United Biotech Private Limited Contribute?
India exported $28.0M worth of Amphotericin through 1,226 shipments from 180 suppliers to 116 countries, serving 390 buyers globally. United Biotech Private Limited contributes $319.8K to this total, accounting for 0.4% of India's Amphotericin exports. United Biotech Private Limited ships Amphotericin to 13 countries through 21 buyers.
What Is the Average Shipment Value for United Biotech Private Limited's Amphotericin Exports?
United Biotech Private Limited's average Amphotericin shipment value is $11.8K per consignment, based on 27 shipments totaling $319.8K. The largest destination is PARAGUAY (63.7% of United Biotech Private Limited's Amphotericin exports).
How Does United Biotech Private Limited Compare to Other Indian Amphotericin Exporters?
United Biotech Private Limited ranks #11 among 180 Indian Amphotericin exporters with a 0.4% market share. The top 3 exporters are BHARAT SERUMS AND VACCINES LIMITED ($15.8M), EMCURE PHARMACEUTICALS LIMITED ($4.5M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($3.8M). United Biotech Private Limited processed 27 shipments to 13 destination countries.
What Amphotericin Formulations Does United Biotech Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMA PRODUCT-AMPHOTERICIN B LIPOSOMAL | $100.0K | 2 |
| PHARMA PRODUC-AMPHOTERICIN B LIPOSOMAL I | $42.3K | 1 |
| PHARMACEUTICAL MEDICINAL PRODUCTS-AMBILIP (AMPHOTERICIN B LIPOSOMAL INJECTION 50MG)BT.ALLI3A3,MFG DT-09/23,EXP-08/25650 | $42.3K | 1 |
| S-AMPHOCIN (AMPHOTERICIN B LIPOSOMAL INJ50MG) BATCH NO.ALLC4A1 MFG.DT:03/24 EXP.DT:02/26 (PACK SIZE : VIAL) | $23.5K | 1 |
| PHARMA PRODUCT ANFOTERICINA B COMPLEXO LIPIDOCO 50MG AMPHOTERICIN B LIPID COMPLEX INJECTION 50MG 10ML B ALIC3C1 M 03 0 | $22.0K | 2 |
| PHARMA: AMFOTIM (AMPHOTERICIN B LIPOSOMA | $17.5K | 1 |
| PHARMA PRODUCT-AMPHOTERICINA B LIPID COM | $11.8K | 1 |
| AMPHOTIN 50 AMPHOTERICIN INJECTION 50MG | $11.2K | 1 |
| AMPHOTIN 50 AMPHOTERICIN B INJECTION IP50 MG BATCH NO ANLI3A3 MANUFACTURING 09/23 EXP 08/25 | $5.1K | 1 |
| AMBILIP (AMPHOTERICIN B LIPOSOMAL INJECTION 50MG) B.: ALLG4A3 M.: 07/2024 E.: 06/2026 | $4.4K | 1 |
United Biotech Private Limited exports 25 distinct Amphotericin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA PRODUCT-AMPHOTERICIN B LIPOSOMAL with 2 shipments worth $100.0K.
How Does United Biotech Private Limited Compare to Nearest Amphotericin Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | JODAS EXPOIM PRIVATE LIMITED | $500.0K | 10 | 1 | $50.0K |
| 9 | GUFIC BIOSCIENCES LIMITED | $422.5K | 16 | 3 | $26.4K |
| 11 | UNITED BIOTECH PRIVATE LIMITED ★ | $319.8K | 27 | 13 | $11.8K |
| 12 | CAPLIN POINT LABORATORIES LIMITED | $315.8K | 9 | 4 | $35.1K |
| 5 | POORNIMA HEALTHCARE | $300.0K | 6 | 1 | $50.0K |
United Biotech Private Limited ranks #11 among 180 Indian Amphotericin exporters. Average shipment value of $11.8K compared to the market average of $155.4K. The closest competitors by value are JODAS EXPOIM PRIVATE LIMITED and GUFIC BIOSCIENCES LIMITED.
Which Indian Ports Ship Amphotericin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 352 | 28.7% |
| SAHAR AIR | 345 | 28.1% |
| Bombay Air | 119 | 9.7% |
| DELHI AIR | 65 | 5.3% |
| DELHI AIR CARGO ACC (INDEL4) | 62 | 5.1% |
| NHAVA SHEVA SEA (INNSA1) | 38 | 3.1% |
| Bombay Air Cargo | 31 | 2.5% |
| BANGALORE ACC (INBLR4) | 20 | 1.6% |
Geopolitical & Trade Policy Impact on United Biotech Private Limited's Amphotericin Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like United Biotech. The Israel-Iran conflict has escalated tensions in the Middle East, leading to disruptions in Red Sea shipping routes and increased freight costs. The Pharmaceuticals Export Promotion Council of India estimates potential losses between ₹2,500 crore and ₹5,000 crore due to these disruptions, affecting companies reliant on Middle Eastern markets. (telanganatoday.com)
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical firms to expand their footprint in the American market. However, recent U.S. tariff policies, including potential increases on pharmaceutical imports, pose a risk to this growth. President Trump's administration has threatened substantial tariff hikes to encourage domestic production, which could impact Indian exporters' competitiveness in the U.S. market. (lemonde.fr)
In the European Union, the implementation of the Falsified Medicines Directive (FMD) necessitates stringent compliance measures for exporters. Indian companies must adapt to these regulatory changes to maintain access to the EU market. The India–EFTA Trade and Economic Partnership Agreement, effective from October 2025, aims to reduce tariffs and promote trade, potentially benefiting exporters like United Biotech. (en.wikipedia.org)
United Biotech Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. FDA, WHO, and EU GMP guidelines set rigorous quality benchmarks that companies must meet to access global markets. While specific regulatory events concerning United Biotech are not detailed, adherence to these standards is essential for sustaining export operations.
The evolving quality requirements, including serialization and traceability mandates under the EU FMD, necessitate continuous investment in compliance infrastructure. Indian exporters must proactively adapt to these changes to ensure uninterrupted market access and maintain their reputation for quality.
About United Biotech Private Limited
United Biotech Private Limited exports 30 products worth $7.0M. Beyond Amphotericin, top products include Ertapenem, Doxorubicin, Voriconazole, Cisplatin, Methylprednisolone. View the complete United Biotech Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Amphotericin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Amphotericin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: United Biotech Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 27 individual customs records matching United Biotech Private Limited exporting Amphotericin, covering 25 formulations to 13 countries via 21 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 116+ countries, 390+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Amphotericin Export Data from United Biotech Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for United Biotech Private Limited's Amphotericin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
United Biotech Private Limited
Full Company Profile →
30 products · $7.0M total trade · 7 categories
Amphotericin Stats
Company Overview
Top Products by United Biotech Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for United Biotech Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Amphotericin. For current shipment-level data, contact TransData Nexus.